RK
Rajeev Kumar Chhabra
About Rajeev Kumar Chhabra
Data last updated:
Rajeev Kumar Chhabra is a Director at Dexbio Pharma Private Limited (since 2018), Whole-Time Director at Raddison Healthcare Private Limited (since 2000) and Director at Venturena Life Science Private Limited (since 2024). The companies operate in Pharma and Chemicals. The 3 current companies with reported revenue have a combined latest revenue of ₹26.83 Cr; the largest is Dexbio Pharma Private Limited at ₹21.52 Cr (FY 2025). Earlier, Rajeev Kumar Chhabra was a Director at Embark Life Science Private Limited (2005–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Dexbio Pharma Private Limited U24232UR2006PTC011840 | Director | 23 Apr 2018 | 2006 | ₹21.52 Cr (FY 2025) | Active |
| Raddison Healthcare Private Limited U24231UP2000PTC025202 | Whole-Time Director | 15 Mar 2000 | 2000 | ₹5.11 Cr (FY 2025) | Active |
| Venturena Life Science Private Limited U24290MH2021PTC373474 | Director | 15 Feb 2024 | 2021 | ₹20 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Embark Life Science Private Limited U24230GJ2005PTC045825 | Director | 05 Apr 2005 | 2005 | ₹26,289 (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Rajeev Kumar Chhabra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anshul Chhabra | 08070427 | Dexbio Pharma Private Limited | Director |
| Venkata Rangaiah Kothuri | 01925729 | Dexbio Pharma Private Limited | Director |
| Venkata Subbarao | 02194896 | Dexbio Pharma Private Limited | Director |
| Bhavesh Alok Goel | 08117190 | Raddison Healthcare Private Limited , Venturena Life Science Private Limited | Director |
| Prashant Goel | 11471561 | Venturena Life Science Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajeev Kumar Chhabra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajeev Kumar Chhabra
Rajeev Kumar Chhabra currently holds 3 directorships: Dexbio Pharma Private Limited (Director, since 23 Apr 2018, revenue ₹21.52 Cr (FY 2025)); Raddison Healthcare Private Limited (Whole-Time Director, since 15 Mar 2000, revenue ₹5.11 Cr (FY 2025)); Venturena Life Science Private Limited (Director, since 15 Feb 2024, revenue ₹20 Lakh (FY 2024)).
Rajeev Kumar Chhabra was first appointed on 15 Mar 2000 as Whole-Time Director at Raddison Healthcare Private Limited. The most recent appointment on record is 15 Feb 2024 at Venturena Life Science Private Limited.
The 3 current companies of Rajeev Kumar Chhabra that report revenue have a combined latest revenue of ₹26.83 Cr: Dexbio Pharma Private Limited ₹21.52 Cr (FY 2025); Raddison Healthcare Private Limited ₹5.11 Cr (FY 2025); Venturena Life Science Private Limited ₹20 Lakh (FY 2024).
Rajeev Kumar Chhabra held 1 earlier board appointment: Embark Life Science Private Limited (Director, 05 Apr 2005 to 11 Feb 2010).
The current boards of Rajeev Kumar Chhabra's companies include Anshul Chhabra (Dexbio Pharma Private Limited), Venkata Rangaiah Kothuri (Dexbio Pharma Private Limited), Venkata Subbarao (Dexbio Pharma Private Limited), Bhavesh Alok Goel (Raddison Healthcare Private Limited), Prashant Goel (Venturena Life Science Private Limited).